E
GRTX

Ergoteles’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Ergoteles’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-29,605
Closed -$240K – 1674
2021
Q3 		$240K Sell
29,605
-10,395
-26% -$89.1K 0.01% 902
2021
Q2 		$393K Buy
+40,000
New +$325K 0.01% 928

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ergoteles's GRTX Position: Q4 2021 in Review

Ergoteles sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2021, closing a stake of 29,605 shares — an estimated $240K sold.

Ergoteles first reported a position in GRTX in Q2 2021 and held it in 2 quarters. The position peaked at $393K in Q2 2021. 44 funds tracked by Wall St. Rank hold GRTX as of Q4 2021.

  • Ergoteles reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Ergoteles sold 29,605 Galera Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $240K.
  • Ergoteles first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Ergoteles's Galera Therapeutics, Inc. Common Stock position peaked at $393K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.